"三倍和计划" (TriPla) 方案用于长期持续的新一代静脉内抗VEGF药物
Federico Beretta1,2, Riccardo Sacconi1,2, Lea Querques2
1School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
European journal of ophthalmology
|January 7, 2025
概括
三重和计划 (TriPla) 方案,结合较新的抗VEGF药物,减少了新血管与年龄相关的黄斑变性 (nAMD) 患者的诊所访问,减轻了医疗保健负担.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 静脉内抗VEGF注射是新血管与年龄相关的黄斑变性 (nAMD) 的标准,但频繁的治疗是繁的.
- 治疗和延长 (T&E) 方案旨在优化治疗间隔,而三重计划 (TriPla) 方案进一步简化了访问.
相关概念视频
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...


